Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-23-073236
Filing Date
2023-09-01
Accepted
2023-09-01 16:15:44
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea184383-f3_canfite.htm F-3 472338
2 OPINION OF DORON TIKOTZKY KANTOR, GUTMAN, NESS, AMIT GROSS AND CO., ISRAELI COUN ea184383ex5-1_canfite.htm EX-5.1 50899
3 OPINION OF GREENBERG TRAURIG, P.A., US COUNSEL TO REGISTRANT ea184383ex5-2_canfite.htm EX-5.2 14485
4 CONSENT OF KOST FORER GABBAY & KASIERER ea184383ex23-1_canfite.htm EX-23.1 2678
5 FILING FEE TABLE ea184383ex-fee_canfite.htm EX-FILING FEES 35804
6 GRAPHIC image_001.jpg GRAPHIC 21952
7 GRAPHIC ex5-1_001.jpg GRAPHIC 5202
8 GRAPHIC ex5-2_001.jpg GRAPHIC 3065
  Complete submission text file 0001213900-23-073236.txt   619268
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-274316 | Film No.: 231232733
SIC: 2834 Pharmaceutical Preparations